Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy
Clinical trial NCT07371247 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07371247
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- ENROLLING_BY_INVITATION
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-20
- Primary completion
- 2027-10-31
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.